BSX vs VSTD · P/E 20, rev $16.75B vs rev $12.8M
Boston Scientific Corp (BSX) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the BSX and VSTD stock pages for the full models.
Not investment advice.